Atomoxetine Dosing for 13-Year-Old, 53 kg Patient
Start atomoxetine at 26.5 mg daily (0.5 mg/kg/day) for at least 3 days, then increase to the target dose of 64 mg daily (1.2 mg/kg/day), administered either as a single morning dose or split into morning and late afternoon/evening doses. 11
Initial Dosing Strategy
Since your patient weighs 53 kg (under 70 kg threshold), follow the weight-based dosing protocol:
- Starting dose: 0.5 mg/kg/day = approximately 26.5 mg daily
- Wait minimum 3 days before titration
- Target dose: 1.2 mg/kg/day = approximately 64 mg daily
- Maximum dose: Do not exceed 1.4 mg/kg (74 mg) or 100 mg, whichever is less 11
Dosing Schedule Options
You have flexibility in administration timing:
- Once daily in the morning, OR
- Divided doses: morning + late afternoon/early evening
The twice-daily, slower titration approach may reduce early adverse events, particularly decreased appetite and somnolence, compared to rapid once-daily titration 2. If tolerability is a concern, consider the divided dosing strategy.
Evidence Supporting 1.2 mg/kg/day Target
Research demonstrates that 1.2 mg/kg/day is as effective as 1.8 mg/kg/day, with no additional benefit at higher doses 3. The dose-response study showed 0.5 mg/kg/day had intermediate efficacy between placebo and higher doses, confirming a graded response that plateaus at 1.2 mg/kg/day 3.
Important Pre-Treatment Considerations
Before initiating atomoxetine, you must:
- Screen for personal or family history of bipolar disorder, mania, or hypomania 11
- Obtain cardiac history including family history of sudden death, cardiovascular symptoms, Wolff-Parkinson-White syndrome, hypertrophic cardiomyopathy, and long QT syndrome 4
- If cardiac risk factors present, obtain ECG and consider cardiology referral 4
Monitoring During Treatment
- Monitor heart rate and blood pressure - atomoxetine can increase both parameters 4
- Watch for gastrointestinal symptoms and somnolence, especially during dose escalation 4
- Be aware of FDA black box warning regarding increased suicidal thoughts (rare but serious) 4
- Monitor appetite and growth parameters over time 4
Special Dosing Adjustments
Only adjust if your patient has:
- Strong CYP2D6 inhibitor use (paroxetine, fluoxetine, quinidine) or known CYP2D6 poor metabolizer status: Start at 0.5 mg/kg/day and only increase to 1.2 mg/kg/day after 4 weeks if symptoms don't improve and initial dose is well tolerated 11
- Hepatic impairment: Reduce doses by 50% (moderate) or 75% (severe) 11
Practical Administration
- Can be taken with or without food 11
- Capsules must be swallowed whole - do not open 11
- No tapering needed when discontinuing 11
Common Pitfall to Avoid
Do not escalate too rapidly - the minimum 3-day waiting period before increasing from starting dose to target dose is critical for tolerability. Rushing this increases risk of gastrointestinal symptoms and somnolence 42.